0001415889-23-005807.txt : 20230403 0001415889-23-005807.hdr.sgml : 20230403 20230403165133 ACCESSION NUMBER: 0001415889-23-005807 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230331 FILED AS OF DATE: 20230403 DATE AS OF CHANGE: 20230403 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROTHBLATT MARTINE A CENTRAL INDEX KEY: 0001106578 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26301 FILM NUMBER: 23793515 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp CENTRAL INDEX KEY: 0001082554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521984749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 MAIL ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 FORMER COMPANY: FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP DATE OF NAME CHANGE: 19990324 4 1 form4-04032023_080422.xml X0407 4 2023-03-31 0001082554 UNITED THERAPEUTICS Corp UTHR 0001106578 ROTHBLATT MARTINE A C/O UNITED THERAPEUTICS CORPORATION 1040 SPRING STREET SILVER SPRING MD 20910 true true false false CHAIRPERSON & CEO 0 Common Stock 2023-03-31 4 M 0 8000 113.08 A 8130 D Common Stock 2023-03-31 4 S 0 1040 218.9444 D 7090 D Common Stock 2023-03-31 4 S 0 1906 220.04 D 5184 D Common Stock 2023-03-31 4 S 0 861 222.1193 D 4323 D Common Stock 2023-03-31 4 S 0 1873 223.2192 D 2450 D Common Stock 2023-03-31 4 S 0 1087 223.8844 D 1363 D Common Stock 2023-03-31 4 S 0 1233 220.9305 D 130 D Common Stock 166 I By Spouse Common Stock 644183 I By Trusts Stock Options 113.08 2023-03-31 4 M 0 8000 0 D 2013-12-31 2023-12-31 Common Stock 8000 168000 D Stock Options 120.26 2017-03-15 2026-03-15 Common Stock 294000 294000 I By Trusts Stock Options 146.03 2018-03-15 2027-03-15 Common Stock 240000 240000 I By Trusts Stock Options 146.03 2020-03-15 2027-03-15 Common Stock 100000 100000 I By Trusts Stock Options 146.03 2020-03-15 2027-03-15 Common Stock 244122 244122 I By Trusts Stock Options 146.03 2018-03-15 2027-03-15 Common Stock 150288 150288 I By Trusts Stock Options 111 2021-03-15 2028-03-15 Common Stock 285103 285103 I By Trusts Stock Options 111 2019-03-15 2028-03-15 Common Stock 213827 213827 I By Trusts Stock Options 135.42 2023-03-15 2027-03-15 Common Stock 500000 500000 I By Trusts Stock Options 117.76 2021-03-15 2027-03-15 Common Stock 500000 500000 I By Trusts This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023. This transaction was executed in multiple trades at prices ranging from $218.44 to $219.305. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $219.455 to $220.43. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $221.595 to $222.565. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $222.605 to $223.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $223.61 to $224.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $220.465 to $221.44. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This stock option was transferred to a trust beneficially owned by the reporting person on March 31, 2023. /s/ John S. Hess, Jr. under Power of Attorney 2023-04-03